Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Michelle L. Lifton"'
Autor:
Leila Eslamizar, Constantinos Petrovas, David J. Leggat, Kathryn Furr, Michelle L. Lifton, Gail Levine, Steven Ma, Christopher Fletez-Brant, Wesley Hoyland, Madhu Prabhakaran, Sandeep Narpala, Kristin Boswell, Takuya Yamamoto, Hua-Xin Liao, David Pickup, Elizabeth Ramsburg, Laura Sutherland, Adrian McDermott, Mario Roederer, David Montefiori, Richard A. Koup, Barton F. Haynes, Norman L. Letvin, Sampa Santra
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-10 (2021)
Abstract The RV144 HIV-1 vaccine trial has been the only clinical trial to date that has shown any degree of efficacy and associated with the presence of vaccine-elicited HIV-1 envelope-specific binding antibody and CD4+ T-cell responses. This trial
Externí odkaz:
https://doaj.org/article/63b38173c836479fba679161167f0413
Autor:
Laura L. Sutherland, Takuya Yamamoto, Barton F. Haynes, Norman L. Letvin, Madhu Prabhakaran, Wesley Hoyland, Sandeep Narpala, David J. Pickup, Steven Ma, Christopher Fletez-Brant, Mario Roederer, Sampa Santra, Adrian B. McDermott, Hua-Xin Liao, Richard A. Koup, Michelle L. Lifton, Elizabeth Ramsburg, Kristin L. Boswell, Gail Levine, Constantinos Petrovas, Leila Eslamizar, David J. Leggat, Kathryn Furr, David C. Montefiori
Publikováno v:
NPJ Vaccines
npj Vaccines, Vol 6, Iss 1, Pp 1-10 (2021)
npj Vaccines, Vol 6, Iss 1, Pp 1-10 (2021)
The RV144 HIV-1 vaccine trial has been the only clinical trial to date that has shown any degree of efficacy and associated with the presence of vaccine-elicited HIV-1 envelope-specific binding antibody and CD4+ T-cell responses. This trial also show